Senti Biosciences Capital Lease Obligations Over Time
| SNTI Stock | USD 2.16 0.02 0.93% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Senti Biosciences Performance and Senti Biosciences Correlation. Senti |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.59) | Revenue Per Share 0.075 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (1.11) |
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Capital Lease Obligations Analysis
Compare Senti Biosciences and related stocks such as Zivo Bioscience, Cadrenal Therapeutics,, and Foghorn Therapeutics Capital Lease Obligations Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVKD | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 43.6 K | 21.4 K | 26 K |
| FHTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.5 M | 62.3 M | 58.3 M | 51.5 M | 45.1 M | 40.1 M |
| SABSW | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 7.4 M | 6.7 M | 4.6 M | 4.9 M | 4.8 M |
| CING | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 1.8 M | 881.1 K | 526.3 K | 473.7 K | 450 K |
| LIPO | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 256.9 K | 208 K | 154.5 K | 136.6 K | 151.2 K |
| FENC | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23 K | 12.7 K |
| MNPR | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.4 K | 0.0 | 0.0 |
| SABS | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 7.4 M | 6.7 M | 4.6 M | 4.9 M | 4.8 M |
| CNTB | 882 K | 882 K | 882 K | 882 K | 882 K | 882 K | 882 K | 882 K | 882 K | 882 K | 913 K | 793 K | 3 M | 465 K | 441.8 K |
| TYRA | 253 K | 253 K | 253 K | 253 K | 253 K | 253 K | 253 K | 253 K | 253 K | 253 K | 142 K | 1.2 M | 2.6 M | 6.5 M | 6.8 M |
| RAPT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9 M | 6.9 M | 5.8 M |
| XLO | 9 M | 9 M | 9 M | 9 M | 9 M | 9 M | 9 M | 9 M | 9 M | 9 M | 11.5 M | 10.9 M | 10.1 M | 11.6 M | 11.4 M |
Senti Biosciences and related stocks such as Zivo Bioscience, Cadrenal Therapeutics,, and Foghorn Therapeutics Capital Lease Obligations description
Senti Biosciences capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Senti Biosciences asset purchases. For example, Senti Biosciences can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Senti Biosciences control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.My Equities
My Current Equities and Potential Positions
| Senti Biosciences | SNTI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.16
Check out Senti Biosciences Performance and Senti Biosciences Correlation. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Senti Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.